In the USA, the National Institutes of Health has outlined significant new investments to support research into amyotrophic lateral sclerosis (ALS). 10 October 2023
The UK is in a strong position to become “a global leader in mRNA medicine,” according to a new report by industry cheerleader the BioIndustry Association (BIA) 4 October 2023
Vaccines Europe—a specialized group of the European Federation of Pharmaceutical Industries and Associations (EFPIA)—has issued a warning. 18 September 2023
Following scrutiny from Democratic senators in Congress, the US Federal Trade Commission has issued a policy statement on the proper listing of pharmaceutical p 18 September 2023
The Belgian pharmaceutical industry has responded to reports of medicine shortages, with local media attributing the blame in some cases to the actions of pharm 11 September 2023
After years of uncertainty stemming from the UK’s departure from the European Union (EU), Prime Minister Rishi Sunak has confirmed that, from Thursday onwards, 7 September 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.